Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04044534
PHASE2
Intranasal Insulin for Posttraumatic Stress Disorder
Sponsor: VA Connecticut Healthcare System
View on ClinicalTrials.gov
Summary
To evaluate if intranasal insulin is effective in reducing PTSD symptoms.
Official title: Intranasal Insulin for Treating Posttraumatic Stress Disorder
Key Details
Gender
All
Age Range
21 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2024-10-31
Completion Date
2026-05-31
Last Updated
2025-09-16
Healthy Volunteers
No
Conditions
Interventions
DRUG
Intranasal insulin
Subjects in this arm will receive intranasal insulin (80 IU per day).
DRUG
Placebo
Subjects in this arm will receive placebo.
Locations (1)
VA Connecticut Healthcare System
West Haven, Connecticut, United States